PIN25 Cost-Effectiveness of Efavirenz Versus Rilpivirine in HIV Patients Initiating First-Line Treatment in the United States
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1301
https://www.valueinhealthjournal.com/article/S1098-3015(12)01366-6/fulltext
Title :
PIN25 Cost-Effectiveness of Efavirenz Versus Rilpivirine in HIV Patients Initiating First-Line Treatment in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01366-6&doi=10.1016/j.jval.2012.03.1301
First page :
A241
Section Title :
Infection
Open access? :
No
Section Order :
834